1. Review: Revisiting the human cholinergic nucleus of the diagonal band of Broca
- Author
-
I. Ahmed, Raymond Chuen-Chung Chang, Steve M. Gentleman, Ronald K. B. Pearce, Alan King Lun Liu, and E. J. Lim
- Subjects
0301 basic medicine ,Parkinson's disease ,1702 Cognitive Sciences ,Hippocampus ,Review ,Nucleus basalis ,NORMAL HUMAN-BRAIN ,0302 clinical medicine ,PARKINSONS-DISEASE ,Pathology ,Neuropathology ,basal forebrain ,Basal forebrain ,Parkinson Disease ,Alzheimer's disease ,HIPPOCAMPAL-FORMATION ,Cholinergic Neurons ,ALZHEIMERS-DISEASE ,SEPTAL GLUTAMATERGIC NEURONS ,FOREBRAIN MAGNOCELLULAR COMPLEX ,medicine.anatomical_structure ,Neurology ,diagonal band of Broca ,Lewy body dementia ,Life Sciences & Biomedicine ,Lewy Body Disease ,Histology ,Clinical Neurology ,ANTERIOR COMMUNICATING ARTERY ,Biology ,cholinergic system ,Pathology and Forensic Medicine ,03 medical and health sciences ,Alzheimer Disease ,Physiology (medical) ,medicine ,Humans ,Cholinergic neuron ,Science & Technology ,Neurology & Neurosurgery ,Lewy body ,Neurosciences ,1103 Clinical Sciences ,medicine.disease ,Diagonal band of Broca ,HUMAN BASAL FOREBRAIN ,030104 developmental biology ,nervous system ,Cholinergic ,Neurosciences & Neurology ,Neurology (clinical) ,GROWTH-FACTOR RECEPTOR ,1109 Neurosciences ,Neuroscience ,030217 neurology & neurosurgery - Abstract
Although the nucleus of the vertical limb of the diagonal band of Broca (nvlDBB) is the second largest cholinergic nucleus in the basal forebrain, after the nucleus basalis of Meynert (nbM), it has not generally been a focus for studies of neurodegenerative disorders. However, the nvlDBB does have an important projection to the hippocampus and discrete lesions of the rostral basal forebrain have been shown to disrupt retrieval memory function, a major deficit seen in patients with Lewy body disorders. One reason for its neglect is that the anatomical boundaries of the nvlDBB are ill defined and this area of the brain is not part of routine diagnostic sampling protocols. We have reviewed the history and anatomy of the nvlDBB and now propose guidelines for distinguishing nvlDBB from other neighbouring cholinergic cell groups for standardising future clinicopathological work. Thorough review of the literature regarding neurodegenerative conditions reveals inconsistent results in terms of cholinergic neuronal loss within the nvlDBB. This is likely to be due to the use of variable neuronal inclusion criteria and omission of cholinergic immunohistochemical markers. Extrapolating from those studies showing significant nvlDBB neuronal loss in Lewy body dementia, we propose an anatomical and functional connection between the cholinergic component of the nvlDBB (Ch2) and the CA2 subfield in the hippocampus which may be especially vulnerable in Lewy body disorders. This article is protected by copyright. All rights reserved.
- Published
- 2018